We bring rigorous experience in health economics methodology to the complexities of health care litigation and policy analysis. Led by Executive Director Cara Scheibling and CEO John Schneider, PhD, our in-house experts and Scientific Advisors have extensive knowledge and experience providing health economics analysis, epidemiology, biostatistics and advanced analytics in the form of advice and testimony in support of a wide range of healthcare litigation and policy applications.
In litigation support, our experts have core capabilities and experience in healthcare cost analysis, analysis of past and future medical bills, calculation of damages and attributable costs. Our Scientific Advisors offer additional capabilities, including testimony, and our Clinical Advisors provide additional capabilities in assessing standards of care and medical need. Our policy analysis experts have core capabilities and experience in economic impact analysis, regulatory impact analysis, access to healthcare, competitive assessment, and disease burden.